Cite
Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach.
MLA
Laupacis, Andreas, et al. “Gaps in the Evaluation and Monitoring of New Pharmaceuticals: Proposal for a Different Approach.” Canadian Medical Association Journal (CMAJ), vol. 169, no. 11, Nov. 2003, pp. 1167–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=11399618&authtype=sso&custid=ns315887.
APA
Laupacis, A., Paterson, J. M., Mamdani, M., Rostom, A., & Anderson, G. M. (2003). Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach. Canadian Medical Association Journal (CMAJ), 169(11), 1167–1170.
Chicago
Laupacis, Andreas, J. Michael Paterson, Muhammad Mamdani, Alaa Rostom, and Geoffrey M. Anderson. 2003. “Gaps in the Evaluation and Monitoring of New Pharmaceuticals: Proposal for a Different Approach.” Canadian Medical Association Journal (CMAJ) 169 (11): 1167–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=11399618&authtype=sso&custid=ns315887.